JP5657813B2 - プラスモジウム感染の検出方法 - Google Patents

プラスモジウム感染の検出方法 Download PDF

Info

Publication number
JP5657813B2
JP5657813B2 JP2013545314A JP2013545314A JP5657813B2 JP 5657813 B2 JP5657813 B2 JP 5657813B2 JP 2013545314 A JP2013545314 A JP 2013545314A JP 2013545314 A JP2013545314 A JP 2013545314A JP 5657813 B2 JP5657813 B2 JP 5657813B2
Authority
JP
Japan
Prior art keywords
blood sample
plasmodium
infection
distribution
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013545314A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014506323A5 (enExample
JP2014506323A (ja
Inventor
デン ボーガールト、ヤン ヴァン
デン ボーガールト、ヤン ヴァン
ハイデン、オリファー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens AG
Original Assignee
Siemens AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens AG filed Critical Siemens AG
Publication of JP2014506323A publication Critical patent/JP2014506323A/ja
Publication of JP2014506323A5 publication Critical patent/JP2014506323A5/ja
Application granted granted Critical
Publication of JP5657813B2 publication Critical patent/JP5657813B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/016—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/018—Platelets
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445—Plasmodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2013545314A 2010-12-23 2011-12-20 プラスモジウム感染の検出方法 Active JP5657813B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102010064131 2010-12-23
DE102010064131.6 2010-12-23
DE102011003101.4A DE102011003101B4 (de) 2010-12-23 2011-01-25 Verfahren zum Nachweis einer Plasmodieninfektion
DE102011003101.4 2011-01-25
PCT/EP2011/073428 WO2012084963A1 (de) 2010-12-23 2011-12-20 Verfahren zum nachweis einer plasmodieninfektion

Publications (3)

Publication Number Publication Date
JP2014506323A JP2014506323A (ja) 2014-03-13
JP2014506323A5 JP2014506323A5 (enExample) 2014-11-20
JP5657813B2 true JP5657813B2 (ja) 2015-01-21

Family

ID=45524485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013545314A Active JP5657813B2 (ja) 2010-12-23 2011-12-20 プラスモジウム感染の検出方法

Country Status (7)

Country Link
US (2) US9605293B2 (enExample)
EP (1) EP2635695B1 (enExample)
JP (1) JP5657813B2 (enExample)
CN (2) CN107815485B (enExample)
DE (1) DE102011003101B4 (enExample)
ES (1) ES2530357T3 (enExample)
WO (1) WO2012084963A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013203839B4 (de) 2013-03-06 2014-10-16 Siemens Healthcare Diagnostics Products Gmbh Verfahren zur Analyse einer Blutprobe und zugehöriges Hämatologie-System
DE102013216362A1 (de) * 2013-08-19 2015-02-19 Siemens Healthcare Diagnostics Products Gmbh Analyseverfahren zur Klassifikationsunterstützung
DE102014200911A1 (de) * 2013-10-09 2015-04-09 Siemens Aktiengesellschaft In-Vitro-Verfahren zum markierungsfreien Bestimmen eines Zelltyps einer Zelle
EP3462170B1 (en) * 2017-09-29 2020-09-16 Siemens Healthcare GmbH Specific malaria detection with digital optical microscopy
CN111781248A (zh) * 2020-07-15 2020-10-16 浙江师范大学 一种疟疾检测装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025A (en) * 1849-01-09 Island
US5045472A (en) 1981-06-26 1991-09-03 Technicon Instruments Corporation Reagent mixture and composition for treating red blood cells to effect sphering
US5284771A (en) * 1991-12-05 1994-02-08 Miles Inc. Reagent compositions and their use in sphering cells
US5888752A (en) * 1995-05-16 1999-03-30 Bayer Corporation Universal rinse reagent and method for use in hematological analyses of whole blood samples
US6114173A (en) 1997-04-03 2000-09-05 Bayer Corporation Fully automated method and reagent composition therefor for rapid identification and characterization of reticulocytes erythrocytes and platelets in whole blood
EP1718966B1 (en) * 2004-02-27 2013-04-24 Beckman Coulter, Inc. Method for detection of malaria and other parasite infections
US7580120B2 (en) 2005-04-07 2009-08-25 Sysmex Corporation Blood analyzer, sample analyzer, and flow cytometer
CN102016577B (zh) 2008-05-09 2015-06-17 希森美康株式会社 血液分析装置,血液分析方法及溶血剂

Also Published As

Publication number Publication date
US9605293B2 (en) 2017-03-28
CN107815485A (zh) 2018-03-20
CN103392005A (zh) 2013-11-13
US20170175162A1 (en) 2017-06-22
JP2014506323A (ja) 2014-03-13
DE102011003101A1 (de) 2012-06-28
CN107815485B (zh) 2021-05-18
ES2530357T3 (es) 2015-03-02
EP2635695B1 (de) 2015-01-28
WO2012084963A1 (de) 2012-06-28
DE102011003101B4 (de) 2016-04-07
US20130337496A1 (en) 2013-12-19
CN103392005B (zh) 2017-12-08
EP2635695A1 (de) 2013-09-11

Similar Documents

Publication Publication Date Title
US12437873B2 (en) Infection detection and differentiation systems and methods
US11644464B2 (en) Sepsis infection determination systems and methods
US11994514B2 (en) Method of determining sepsis in the presence of blast flagging
CN114096845A (zh) 用于评估对感染的免疫反应的系统和方法
JP5657813B2 (ja) プラスモジウム感染の検出方法
KR20150091049A (ko) Cpd 데이터를 이용한 결핵 선별검사
US20240353311A1 (en) Blood cell analyzer, method and use of infection marker parameter
CN110241253B (zh) 用于检测登革感染的方法
US20240361231A1 (en) Blood cell analyzer, method for indicating intection status and use of infection marker parameter
US20230393164A1 (en) Methods for evaluating mis-c associated with covid-19
Kıymaz et al. Predictive role of non-viral leukocyte parameters in tracking the development and progression of Crimean-Congo hemorrhagic fever
Hassan et al. Assessment of complete blood count and D-dimer among patients with Plasmodium falciparum malaria
CN116685852A (zh) 使用参数检测医疗状况、严重性、风险和敏度
US20250391567A1 (en) Infection detection and differentiation systems and methods
US20240353310A1 (en) Blood cell analyzer, method for indicating infection status and use of infection marker parameter
Hyder et al. A simple point score model for prediction of Covid-19 in some Egyptian patients

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140708

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20141002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141007

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141028

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141126

R150 Certificate of patent or registration of utility model

Ref document number: 5657813

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250